Dan R. Burns
Chief Executive Officer at InfaCare Pharmaceutical Corp.
Dan R. Burns active positions
| Companies | Position | Start | End |
|---|---|---|---|
InfaCare Pharmaceutical Corp.
 InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Director/Board Member | 2011-06-08 | - |
| Chief Executive Officer | 2007-03-31 | - | |
| President | 2007-03-31 | - |
Career history of Dan R. Burns
Former positions of Dan R. Burns
| Companies | Position | Start | End |
|---|---|---|---|
| MANNKIND CORPORATION | Corporate Officer/Principal | - | 2007-02-15 |
HealthTalk, Inc.
 HealthTalk, Inc. Internet Software/ServicesTechnology Services HealthTalk, Inc. provides online health information services. It offers services in the areas such as asthma, chronic lymphocytic leukemia, psoriasis, migraine, sclerosis, and rheumatoid arthritis. The company was founded by Greg Harris in 2007 and is headquartered in Seattle, WA. | Chief Executive Officer | 1999-12-31 | 2001-12-31 |
ProScript, Inc.
 ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Chief Executive Officer | 1997-12-31 | 1998-12-31 |
Trophix Pharmaceuticals, Inc.
 Trophix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of NPS Allelix Corp., Trophix Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in South Plainfield, NJ. The company was founded by Jeffrey F. McKelvy. Trophix Pharmaceuticals was acquired by Allelix Biopharmaceuticals, Inc. on July 30, 1997 for $27 million. | Chief Operating Officer | 1996-12-31 | 1997-12-31 |
| President | 1996-12-31 | 1997-12-31 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
Training of Dan R. Burns
| McMaster University | Undergraduate Degree |
| Mohawk College | Undergraduate Degree |
Statistics
International
| United States | 7 |
| Canada | 3 |
Operational
| Chief Executive Officer | 3 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| Private companies | 4 |
|---|---|
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Health Technology |
Trophix Pharmaceuticals, Inc.
Trophix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of NPS Allelix Corp., Trophix Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in South Plainfield, NJ. The company was founded by Jeffrey F. McKelvy. Trophix Pharmaceuticals was acquired by Allelix Biopharmaceuticals, Inc. on July 30, 1997 for $27 million. | Health Technology |
ProScript, Inc.
ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Health Technology |
HealthTalk, Inc.
HealthTalk, Inc. Internet Software/ServicesTechnology Services HealthTalk, Inc. provides online health information services. It offers services in the areas such as asthma, chronic lymphocytic leukemia, psoriasis, migraine, sclerosis, and rheumatoid arthritis. The company was founded by Greg Harris in 2007 and is headquartered in Seattle, WA. | Technology Services |
- Stock Market
- Insiders
- Dan R. Burns
- Experience
